BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study

John Munkhaugen, Dan Atar, Morten Wang Fagerland et al.|American Heart Journal|2018

Cited by 50